BioNTech SE
114.42
1.99 (1.77%)
At close: Jan 15, 2025, 11:39 AM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
PE Ratio 24.57 3.69 5.08 1.13K -35.91 -61.27 -34.35 n/a
PS Ratio 5.99 2.01 2.76 35.62 59.25 23.06 47.77 n/a
PB Ratio 1.13 1.73 4.40 12.53 13.04 11.06 -59.69 n/a
P/FCF Ratio 4.90 2.63 71.07 -173.7 -23.86 -23.35 -26.68 n/a
P/OCF Ratio 4.26 2.56 58.77 -1.28K -32.41 -50.57 -55.98 n/a
OCF/S Ratio 1.41 0.78 0.05 -0.03 -1.83 -0.46 -0.85 n/a
Debt / Equity Ratio 0.01 0.01 0.03 0.18 0.14 0.20 -1.02 0.88
Quick Ratio 9.26 7.28 4.18 2.64 3.97 3.51 1.17 5.56
Current Ratio 9.43 7.43 4.33 2.75 4.05 3.56 1.20 5.62
Asset Turnover 0.17 0.74 1.20 0.21 0.14 0.20 0.16 n/a
Interest Coverage 1.21K 668.93 2.83K -1.27 -105.66 -31.29 -90.65 n/a
Return on Equity (ROE) 0.05 0.47 0.87 0.01 -0.36 -0.18 1.74 n/a
Return on Assets (ROA) 0.04 0.41 0.65 0.01 -0.22 -0.07 -0.23 n/a
Return on Capital (ROIC) 0.03 0.62 1.24 -0.05 -0.28 -0.1 -0.28 n/a
Dividend Yield n/a 0.01 n/a n/a n/a n/a n/a n/a
Payout Ratio n/a 0.05 n/a n/a n/a n/a n/a n/a
Gross Profit Margin 84.29% 73.82% 79.66% -46.03% -124.54% -22.85% -53.92% n/a
Net Profit Margin 24.36% 54.50% 54.24% 3.15% -165% -37.64% -139.05% n/a
Pretax Profit Margin 31.06% 74.83% 79.29% -30.23% -165.25% -37.36% -139.46% n/a
Operating Profit Margin 18.08% 73.03% 80.54% -17.09% -167.16% -42.21% -99.48% n/a
FCF Margin 122.18% 76.34% 3.88% -20.51% -248.29% -98.79% -179.07% n/a
EBITDA Margin 28.48% 71.79% 79.06% -21.79% -140.25% -23.52% -79.13% n/a